Executive Director Shabbir Imber Safdar argued that the committee's decision is "a serious setback for patient safety," warning that it could legitimize compounds lacking adequate clinical evidence and increase the spread of potentially unsafe products through wellness clinics, medical spas, and online platforms
Got a lump after your injection
Sleep and nutrition help the body use repair signals well
July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee BPC-157, KPV, TB-500, and MOTs-C bulk drug substances
When weight comes off quickly, there's less opportunity to preserve and rebuild muscle tissue
Nociceptive Pain: What It Is, Causes, Treatment & Types